Kiromic Biopharma, Inc. Business Operations Contracts & Agreements

9 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties
Settlement Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties
Settlement Agreements
Kiromic Biopharma, Inc.
Biotechnology
NY
2022
Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark
Indemnification Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2022
Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani
Indemnification Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2022
Form of Director Indemnification Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors
Indemnification Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020
Form of Director Services Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors
Services Agreements
Kiromic Biopharma, Inc.
Biotechnology
TX
2020
Collaboration Agreement, dated February 6, 2020, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc
Collaboration Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Collaboration Agreement, dated February 4, 2019, between University of Texas MD Anderson Cancer Center and Kiromic BioPharma, Inc
Collaboration Agreements
Kiromic Biopharma, Inc.
Biotechnology
2020
Voting Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc., certain investors and certain stockholders
Voting Agreements
Kiromic Biopharma, Inc.
Biotechnology
DE
2020